-

Moderna Greed Cost Pandemic Response One Year and Counting, Says AHF

LOS ANGELES--(BUSINESS WIRE)--AIDS Healthcare Foundation (AHF) today condemned Moderna for its more than year-long refusal to share vaccine know-how and concurrently voiced support for a scientific effort in South Africa that has almost yielded a copy of Moderna’s messenger-RNA-based vaccine against COVID-19, without Moderna’s involvement, according to Nature.

“Countries are forced to spend months and years reverse-engineering technologies that Moderna can readily handover tomorrow and thereby save millions of lives. This level of cynical self-interest and greed by Big Pharma is reprehensible, especially after taxpayers paid billions of dollars for the research in the first place,” said AHF President Michael Weinstein. “We urge President Biden to invoke the Defense Production Act to accelerate vaccine production, and for other leaders of the wealthiest economies to press vaccine makers to share their know-how and technology immediately. We can’t afford to let precious time tick by, while millions continue to perish from COVID-19.”

In 2021, a South African consortium established the first COVID-19 mRNA vaccine technology transfer hub, which included Afrigen Biologics and Vaccines in an effort to make these highly effective vaccines available across Africa. To date, mRNA vaccine makers Moderna, Pfizer, and BioNTech have sent most of their doses, more than 70%, to rich countries, while barely 11% of people in low-income countries have gotten even one dose of a vaccine.

Visit VaccinateOurWorld.org to learn more.

AIDS Healthcare Foundation (AHF), the largest global AIDS organization, currently provides medical care and/or services to over 1.6 million clients in 45 countries worldwide in the US, Africa, Latin America/Caribbean, the Asia/Pacific Region and Europe. To learn more about AHF, please visit our website: www.aidshealth.org, find us on Facebook: www.facebook.com/aidshealth and follow us on Twitter: @aidshealthcare and Instagram: @aidshealthcare

Contacts

US MEDIA CONTACT:
Ged Kenslea, Senior Director, Communications, AHF
+1.323.308.1833 work +1.323.791.5526 mobile
gedk@aidshealth.org

Denys Nazarov, Director of Global Policy &
Communications, AHF
+1 323.308.1829
denys.nazarov@ahf.org

AIDS Healthcare Foundation


Release Versions

Contacts

US MEDIA CONTACT:
Ged Kenslea, Senior Director, Communications, AHF
+1.323.308.1833 work +1.323.791.5526 mobile
gedk@aidshealth.org

Denys Nazarov, Director of Global Policy &
Communications, AHF
+1 323.308.1829
denys.nazarov@ahf.org

Social Media Profiles
More News From AIDS Healthcare Foundation

AHF Hails Introduction of Protect 340B Act of 2026

WASHINGTON--(BUSINESS WIRE)--AHF Hails Introduction of Protect 340B Act of 2026...

AHF Urges African Nations to Take Charge of Medicines Regulation

KIGALI, Rwanda--(BUSINESS WIRE)--With more than 20 African Union Member States yet to ratify the African Medicines Agency (AMA) Treaty, AIDS Healthcare Foundation (AHF) calls on African governments to accelerate ratification and regulatory harmonisation to expand access to affordable medicines and unlock Africa’s pharmaceutical manufacturing potential.The call comes as AMA convenes its inaugural week in Kigali, Rwanda, from 25–30 October 2026, against a backdrop of continued dependence on import...

Treatment = Life: AHF Reaches 2 Million Patients in Care in Africa

KAMPALA, Uganda--(BUSINESS WIRE)--AIDS Healthcare Foundation (AHF) has surpassed 2 million patients in care across 15 African countries, marking a historic achievement 25 years after beginning its first programs outside the United States in South Africa and Uganda. With programs in four additional countries expected to launch in 2027, AHF is recognizing the communities and partnerships behind this progress while calling for urgent action to close persistent gaps in the HIV response. AHF’s work...
Back to Newsroom